Advances in the development of Artificial Hearts in the Department of Energy and Power Engineering of Tsinghua University

被引:0
作者
Huang B. [1 ]
Li H. [1 ]
Lu B. [2 ]
Zuo Z. [1 ]
Luo X. [1 ]
Liu S. [1 ]
机构
[1] Department of Energy and Power Engineering, Tsinghua University, Beijing
[2] Zhejiang Qingke Pumping Medical Technology Limited, Taizhou
来源
Qinghua Daxue Xuebao/Journal of Tsinghua University | 2022年 / 62卷 / 04期
关键词
Artificial Hearts; Centrifugal pumps; Hemolysis; Hydrodynamics;
D O I
10.16511/j.cnki.qhdxxb.2022.25.030
中图分类号
学科分类号
摘要
The latest generation of Artificial Hearts are using centrifugal blood pumps to provide important support for patients with cardiovascular diseases. This paper describes the advances in the development of Artificial Hearts in the Department of Energy and Power Engineering of Tsinghua University. A pump design optimization method was proposed based on the maximum scalar shear stress for the hemolysis standard to raduce the calculational load and improve the optimization efficiency. A blood-cell-damage model based on the turbulent viscous dissipative stress was developed for better prediction. Both extracorporeal pumps with bearings and left ventricular assist device (LVAD) prototypes with magneto-hydraulic suspensions have been developed with studies of their hydraulics. Model predictions agree with the experimental data with an error of 3.6%. A medical fluid flow experimental system has been developed to improve research on Artificial Heart prototypes through evaluations of the physiological effects of new Artificial Heart designs. © 2022, Tsinghua University Press. All right reserved.
引用
收藏
页码:746 / 757
页数:11
相关论文
共 41 条
[1]  
The Writing Committee of the Report on Cardiovascular Health and Diseases in China, Report on cardiovascular health and diseases burden in China: An updated summary of 2020, Chinese Circulation Journal, 36, 6, pp. 521-545, (2021)
[2]  
CHRISTIE J D, EDWARDS L B, KUCHERYAVAYA A Y, Et al., The registry of the International Society for Heart and Lung Transplantation: Twenty-eighth adult lung and heart-lung transplant report-2011, The Journal of Heart and Lung Transplantation, 30, 10, pp. 1104-1122, (2011)
[3]  
LUND L H, KHUSH K K, CHERIKH W S, Et al., The registry of the International Society for Heart and Lung Transplantation: Thirty-fourth adult heart transplantation report-2017
[4]  
focus theme: Allograft ischemic time, The Journal of Heart and Lung Transplantation, 36, 10, pp. 1037-1046, (2017)
[5]  
AL MASRI E, AL SHAKAKI M, WELP H, Et al., Long-term follow-up of patients supported with the HeartWare left ventricular assist system, Artificial Organs, 44, 10, pp. 1061-1066, (2020)
[6]  
KAWAHITO K, NOSe Y., Hemolysis in different centrifugal pumps, Artificial Organs, 21, 4, pp. 323-326, (1997)
[7]  
SELMI M, CHIU W C, CHIVUKULA V K, Et al., Blood damage in Left Ventricular Assist Devices: Pump thrombosis or system thrombosis?, The International Journal of Artificial Organs, 42, 3, pp. 113-124, (2019)
[8]  
KIRKLIN J K, NAFTEL D C, PAGANI F D, Et al., Seventh INTERMACS annual report: 15, 000 patients and counting, The Journal of Heart and Lung Transplantation, 34, 12, pp. 1495-1504, (2015)
[9]  
RAVICHANDRAN A K, PARKER J, NOVAK E, Et al., Hemolysis in left ventricular assist device: A retrospective analysis of outcomes, The Journal of Heart and Lung Transplantation, 33, 1, pp. 44-50, (2014)
[10]  
WHITSON B A, ECKMAN P, KAMDAR F, Et al., Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients, The Annals of Thoracic Surgery, 97, 6, pp. 2097-2103, (2014)